Moderna Inc. (MRNA) Q3 2026 (USD): EPS 0.38 (exp. -1.10), Revenue 1.3bln (exp. 890mln). FY revenue growth seen between 15-25%

Newsquawk Staff · 6 Nov 2026, 12:05 UTC

Moderna Inc. (MRNA) Q3 2026 (USD): EPS 0.38 (exp. -1.10), Revenue 1.3bln (exp. 890mln). FY revenue growth seen between 15-25%.

What our morning note said

Stocks · US Market Open, 6 Nov, 10:48 UTC

APAC stocks were pressured; KOSPI slumped 6% following hefty losses in Samsung and SK Hynix.

Newsquawk Daily

What moved overnight, where stocks, bonds, currencies and oil stand, and what’s due today. Written by our analysts.

Both market-open notes, EU and US, every weekday. No account needed. Unsubscribe any time.

This headline was on the Newsquawk live feed at 11:45 UTC.

Use the Platform opens our news terminal in your browser, with the live headline feed. It’s news, not a broker.

Free. No signup, no card.

Case studies

FX headlines from our feed, and what the market did next.

Iranian President Pezeshkian says the Supreme Leader has granted the government some authority on dialogue, ISNA reports.
EUR/USD+0.1%
ECB policymakers see a December rate hike followed by a pause; New ECB staff estimates show the rise in bond yields cutting growth by a cumulative 100bps and inflation by 90bps in 2027-28 vs the September baseline, according to reports, citing sources.
EUR/USD−0.1%
ECB President Lagarde (Q&A) says policymakers believe they are in a good position to wait for incoming information. The situation they are in could have warranted a hike.
EUR/USD+0.1%

See all 221